You have 9 free searches left this month | for more free features.

Angiomyolipoma

Showing 51 - 74 of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lipid Metabolism, Inborn Errors, Hypercholesterolemia, Autosomal Dominant, Hyperlipidemias Trial in United States (mipomersen

Completed
  • Lipid Metabolism, Inborn Errors
  • +13 more
  • mipomersen sodium
  • Chicago, Illinois
  • +4 more
Aug 1, 2016

Hypercholesterolemia, Coronary Heart Disease Trial in United States (Mipomersen sodium, Placebo)

Completed
  • Hypercholesterolemia
  • Coronary Heart Disease
  • Mipomersen sodium
  • Placebo
  • Birmingham, Alabama
  • +61 more
Aug 1, 2016

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, Sulfonylurea, Metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Miranda, New South Wales, Australia
  • +446 more
Mar 21, 2017

Breast Cancer Trial in Worldwide (Letrozole, Anastrozole)

Completed
  • Breast Cancer
  • Birmingham, Alabama
  • +262 more
Mar 20, 2016

Adalimumab in Moderate to Severe Psoriasis in Spain

Completed
  • Moderate-to-severe Chronic Plaque Psoriasis
    • (no location specified)
    Dec 1, 2015

    Atypical Hemolytic Uremic Syndrome Trial in Worldwide (eculizumab)

    Completed
    • Atypical Hemolytic Uremic Syndrome
    • Toronto, Canada
    • +12 more
    Jun 30, 2015

    Atypical Hemolytic Uremic Syndrome Trial in Worldwide (eculizumab)

    Completed
    • Atypical Hemolytic Uremic Syndrome
    • Toronto, Canada
    • +12 more
    Jun 30, 2015

    Ovarian Cancer, Endometrial Cancer Trial in Baltimore (everolimus and letrozole)

    Unknown status
    • Ovarian Cancer
    • Endometrial Cancer
    • everolimus and letrozole
    • Baltimore, Maryland
      Sinai Hospital of Baltimore, Inc.
    May 18, 2015

    Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Cincinnati (RAD001)

    Completed
    • Tuberous Sclerosis
    • Lymphangioleiomyomatosis
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Sep 23, 2013

    Neurofibromatosis Type 1, Plexiform Neurofibroma, Neurofibromatoses Trial in Creteil (RAD001: Everolimus)

    Completed
    • Neurofibromatosis Type 1
    • +2 more
    • RAD001: Everolimus
    • Creteil, France
      Henri Mondor Hospital
    Nov 13, 2014

    Tuberous Sclerosis, Angiolipoma Trial in Cincinnati (everolimus (RAD001))

    Completed
    • Tuberous Sclerosis
    • Angiolipoma
    • everolimus (RAD001)
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Sep 17, 2013

    Colorectal Cancer Trial in Worldwide (Tivozanib, Bevacizumab, mFOLFOX6)

    Completed
    • Colorectal Cancer
    • Gilbert, Arizona
    • +72 more
    Jun 9, 2015

    Chronic Myeloid Leukemia Trial in Worldwide (ponatinib, imatinib (Gleevec/ Glivec))

    Terminated
    • Chronic Myeloid Leukemia
    • Burbank, California
    • +169 more
    Nov 5, 2014

    Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Interferon beta-1a, Alemtuzumab 12 mg, Alemtuzumab 24 mg)

    Completed
    • Multiple Sclerosis, Relapsing-Remitting
    • Interferon beta-1a
    • +2 more
    • Scottsdale, Arizona
    • +48 more
    Jan 6, 2015

    Observational Trial With Enbrel

    Completed
    • Rheumatoid Arthritis
    • Muenster, NRW, Germany
      Pfizer Investigational Site
    Jul 25, 2014

    Malignant PEComa (Perivascular Epithelioid Cell Tumors) Trial in Barcelona (BEZ235)

    Withdrawn
    • Malignant PEComa (Perivascular Epithelioid Cell Tumors)
    • Barcelona, Cataluña, Spain
      Novartis Investigative Site
    Aug 1, 2013

    Angiomyolipoma Trial (Sirolimus)

    Completed
    • Angiomyolipoma
    • (no location specified)
    Mar 7, 2012

    Effect of Somatropin on Growth Hormone Deficient Adults

    Completed
    • Hypopituitarism
    • +2 more
    • Somatropin (rDNA origin)
    • (no location specified)
    Mar 25, 2014

    Rheumatoid Arthritis Trial in Worldwide (Canakinumab, Placebo)

    Completed
    • Rheumatoid Arthritis
    • Anniston, Alabama
    • +16 more
    Jan 14, 2014

    Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (Aliskiren, Placebo)

    Terminated
    • Type 2 Diabetes Mellitus
    • Cardiovascular Disease
    • Birmingham, Alabama
    • +777 more
    Apr 1, 2014

    Alzheimer Trial in Worldwide (Rivastigmine 5 cm^2, Rivastigmine 10 cm^2, Rivastigmine 15 cm^2)

    Completed
    • Alzheimer Disease
    • Rivastigmine 5 cm^2
    • +4 more
    • Birmingham, Alabama
    • +144 more
    Sep 17, 2012

    Diabetes, Type 2 Trial in Investigative Site, Investigative Sites (Valsartan 160 mg + nateglinide 60 mg, Valsartan 160 mg +

    Completed
    • Diabetes Mellitus, Type 2
    • Valsartan 160 mg + nateglinide 60 mg
    • +3 more
    • Investigative Site, New Jersey
    • +37 more
    Jun 27, 2011

    Lymphangioleiomyomatosis Trial in Canada, Japan, United States (Sirolimus, Placebo sirolimus)

    Unknown status
    • Lymphangioleiomyomatosis
    • Los Angeles, California
    • +12 more
    Aug 27, 2009

    Official Record of Patients Diagnosed With

    Completed
    • Leiomyomatosis
      • Bethesda, Maryland
        National Heart, Lung and Blood Institute (NHLBI)
      Mar 3, 2008